Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of DTacP-sIPV Vaccine in Children Aged 2 Months to 6 Years
NCT07891104Phase 2Recruiting
- Sponsor
- Institute of Medical Biology
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Institute of Medical Biology. Started Oct 2026; status: recruiting.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis + inactivated poliovirus vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT07891104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891104.